Loading...

Aptorum Group Limited

APM.PAEURONEXT
Healthcare
Biotechnology
3.21
0.00(0.00%)

Aptorum Group Limited (APM.PA) Stock Overview

Explore Aptorum Group Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.1/100

Key Financials

Market Cap8.8M
P/E Ratio0.82
EPS (TTM)$-4.54
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$27.55

APM.PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aptorum Group Limited (APM.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $27.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.82 and a market capitalization of 8.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;